NasdaqGS:IDXXMedical Equipment
A Look At IDEXX Laboratories (IDXX) Valuation After Its Cancer Dx Panel Expansion In The United Kingdom
IDEXX Laboratories (IDXX) recently extended its Cancer Dx Panel to veterinary practices in the United Kingdom, giving investors fresh product news to weigh alongside upcoming first quarter 2026 results and the existing companion animal diagnostics business.
See our latest analysis for IDEXX Laboratories.
Despite the Cancer Dx expansion and the upcoming Q1 2026 earnings release, IDEXX Laboratories’ recent 1 month share price return of 6.25% and 3 month share price return of 21.08% contrast...